ARGININSALZE EINES TLR7 AGONISTEN

Patent europeic · EP2822947 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2822947
Numer da la dumonda
EP13708142
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
07-03-2013
Publitgà
14-01-2015
Concedì
03-08-2016
La protecziun finescha il pli tard
06-03-2033
Proxima taxa annuala scadenta
31-03-2027
Classas IPC
C07D 471/04 (2006.01)
A61K 39/39 (2006.01)
C07F 9/6561 (2006.01)
A61P 37/04 (2006.01)
A61K 31/675 (2006.01)
Prioritad
US 201261608011 P 07.03.2012
Dumonda PCT
PCT/EP2013/054548 07.03.2013
Publicaziun PCT
WO2013/131985 12.09.2013
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-04-2026

    Midada

    Published in Swissreg on 01.04.2026

  2. 01-04-2025

    Midada

    Published in Swissreg on 01.04.2025

  3. 01-04-2024

    Midada

    Published in Swissreg on 01.04.2024

  4. 01-04-2023

    Midada

    Published in Swissreg on 01.04.2023

  5. 19-08-2016

    Represchentant inscrit

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 19.08.2016

  6. 03-08-2016

    Concedì

    Published in Swissreg on 03.08.2016

Partidas

Possessur

GlaxoSmithKline Biologicals SA

Rue de l'Institut 89, 1330 Rixensart, BE

Represchentant

Isler & Pedrazzini AG

Postfach 1772, 8027 Zürich

Inventur

DODD, Stephanie Kay

Cambridge, Massachusetts 02139, US

JAIN, Siddartha

Emeryville, California 94608, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.